ReviewPlant molecular biology2026
Evolution, structural diversity and functional plasticity of plant derived multifunctional proteases and α-amylases inhibitors.
Review in Plant molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Plant derived multifunctional inhibitors (MFIs) are an important class of plant defense proteins that disrupt insect digestion by simultaneously impairing protein and carbohydrate catabolism. With the increasing knowledge of inhibitors of plant enzymes, MFIs have become a separate functional group. In this review we propose an extended definition that encompasses the classical inhibitors acting on structurally unrelated enzymes and also inhibitors acting on enzymes of the same substrate pathway, e.g. α-amylase/α-glucosidase and trypsin/chymotrypsin systems. Most of the MFIs consist of single polypeptide chains with spatially separated inhibitory sites, which allow simultaneous inhibition of several enzyme targets. The structural organization, inhibitory mechanism and evolutionary diversification of these inhibitors are reviewed with emphasis on the major families including Bowman-Birk, Kunitz-type and cereal trypsin/α-amylase inhibitors. Their domain architecture, disulfide bond patterns and structure-function relationships are discussed in view of their remarkable stability and functional versatility. Recent advances in computational structural biology, including molecular docking, molecular dynamics simulations, and AlphaFold-based protein structure prediction, have promoted mechanistic insights and enabled structure-guided engineering of improved inhibitors. The review also discusses the evolutionary origin of MFIs through gene duplication, domain shuffling, sequence diversification and adaptive evolution, and emerging approaches such as protein engineering, recombinant expression, synthetic biology and genome editing. Finally, the applications in crop protection, development of biopesticides and food biotechnology, as well as the challenges regarding insect adaptation, evolution of resistance, biosafety and ecological impacts are critically discussed. Bridging current gaps in structural characterization and in vivo validation is necessary for the translation of MFIs into sustainable agricultural and biotechnological applications.
Indexed as
Identifiers
42867572What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.